We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App




New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use

By LabMedica International staff writers
Posted on 02 Apr 2024
Print article
Image: The new generation StatStrip Glucose Hospital Meter has obtained FDA 510k clearance (Photo courtesy of Nova Biomedical)
Image: The new generation StatStrip Glucose Hospital Meter has obtained FDA 510k clearance (Photo courtesy of Nova Biomedical)

A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and FDA clearance for use with critically ill patients.

Nova Biomedical (Waltham, MA, USA) has introduced the New Generation StatStrip Glucose Hospital Meter System to the U.S. market. This system continues to utilize the only FDA-cleared test strip for glucose testing of critically ill patients. More than 200 published clinical studies validate StatStrip's accurate and reliable results, highlighting its ability to eliminate interference from a wide range of medications (over 8,000 tested) and the complex physiological conditions often encountered among patients in intensive care settings with complex medical conditions and drug regimens. The New Generation StatStrip enhances bedside glucose testing with several key advancements, including a transition to a Linux® operating system for improved cybersecurity against viruses and other malware, and extension of its hematocrit range to 5-75%.

The New Generation StatStrip now comes with RFID technology, an illuminated barcode scanner, and touchscreen keyboard entry for easier submission of operator ID and patient ID. It also features a wireless meter for faster, easier, and safer charging. The battery is charged in the meter’s sealed compartment, with the charger automatically shutting off when the meter becomes fully charged. Additionally, StatStrip’s new meter casing has been built using a unique soft-touch over-molding material that can withstand rough use and exposure to harsh disinfecting agents.

“We are proud to now offer our StatStrip New Generation platform for glucose testing,” said Rick Rollins, StatStrip Product Manager. “The new meter gives current StatStrip users and non-users a clear upgrade for easier hospital glucose testing while ensuring accurate, interference- free, and safe use with critically ill patients.”

Related Links:
Nova Biomedical

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.